Bunkerhill MAC vs iPredict Eye Screening
AI Verdict
Choose Bunkerhill MAC if…
Choose Bunkerhill MAC if your cardiology or radiology department aims to proactively identify patients at risk for mitral annular calcification (MAC) using existing, routine CT scans. This tool is ideal for integrating MAC detection and quantification into automated workflows for early cardiovascular risk stratification and seamless care coordination within the Carebricks platform.
View Bunkerhill MAC →Choose iPredict Eye Screening if…
Choose iPredict Eye Screening if your primary care clinic, ophthalmology practice, or telemedicine service requires a fast, non-invasive AI-powered solution for comprehensive screening of age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma. This tool also offers valuable integrated risk prediction for systemic diseases like stroke and heart attack, making it suitable for broader patient health assessments.
View iPredict Eye Screening →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill MAC | iPredict Eye Screening |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud-based, integrates with EHRs. | Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
iPredict Eye ScreeningTool B, iPredict Eye Screening, emphasizes an 'easy to operate, non-invasive, with an advanced touchscreen interface' and rapid results (under 5 minutes for the test, under 60 seconds for the report). This suggests a user-friendly experience for direct screening, requiring minimal training (less than 1 hour). While Tool A, Bunkerhill MAC, focuses on seamless integration into existing radiology workflows and EHRs, Tool B's direct operational ease for a broader user base gives it an edge in general usability.
Clinical Value
iPredict Eye ScreeningBoth tools are FDA-cleared and address important health concerns. However, Tool B, iPredict Eye Screening, offers a broader clinical scope by screening for multiple prevalent eye conditions (Diabetic Retinopathy, Age-related Macular Degeneration, and Glaucoma) and providing risk prediction for systemic diseases like stroke and heart attack. It also provides specific high accuracy metrics (e.g., AMD sensitivity 86.86%, specificity 94.13%). Tool A focuses on a single, albeit significant, cardiovascular risk factor (MAC) from routine CT scans.
Pricing & Value
iPredict Eye ScreeningTool B, iPredict Eye Screening, offers more transparency in its pricing model, detailing a 'per patient screening on a Software as a Service (SaaS) model, estimated $10-$20 per patient (20%-40% of Medicare/commercial payor reimbursement)'. [cite: JSON] This provides potential buyers with a clearer understanding of the cost structure and potential return on investment. While Tool A, Bunkerhill MAC, has secured a CMS reimbursement pathway, its pricing is only available upon contact, making a direct comparison of value less transparent.
Enterprise Readiness
Bunkerhill MACBoth tools are FDA-cleared, cloud-based, and integrate with EHRs. However, Tool A, Bunkerhill MAC (via Bunkerhill Health), explicitly states compliance with HIPAA, SOC 2, and ISO 27001:2022 in its Trust Center. These additional certifications demonstrate a more comprehensive and transparent commitment to enterprise-level security, data governance, and compliance standards, providing stronger assurance for large-scale deployments.
Innovation
Bunkerhill MACTool A, Bunkerhill MAC, stands out with its explicit mention of 'Generative AI for clinical reasoning and action' and integration with the 'Carebricks generative AI platform'. [cite: JSON, 11, 20] This platform is designed to go beyond mere detection to support automated workflows for follow-up and care coordination, and can extract and act on information from unstructured encounter notes for deeper patient understanding. This represents a higher level of AI sophistication focused on broader clinical intelligence and actionable insights.
Support & Docs
TieNeither the provided structured facts nor the web search results offered specific details regarding the availability, scope, or quality of support services or documentation for either Bunkerhill MAC or iPredict Eye Screening. Without this information, it is not possible to distinguish between the two tools on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill MAC | iPredict Eye Screening |
|---|---|---|
| Name | Bunkerhill MAC | iPredict Eye Screening |
| Primary AI Focus | Detects and quantifies mitral annular calcification (MAC) on routine CT scans. | Screens for age-related macular degeneration (AMD), Diabetic Retinopathy (DR), and Glaucoma; provides risk prediction for systemic diseases like stroke and heart attack. |
| Company | Bunkerhill Health | iHealthScreen |
| Integration | Integrates with existing EHRs and clinical systems via Carebricks platform. | Integrates with EHR and telemedicine services. |
| Target Specialties | Cardiology, Radiology | Family Medicine, Internal Medicine, Ophthalmology |
| Key Differentiator | Integrates with the Carebricks generative AI platform for clinical reasoning and action; analyzes routine, non-gated chest CT scans. | Fast results: test completed in less than 5 minutes, report in under 60 seconds; high accuracy (approximately 95% on average). |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill MAC and iPredict Eye Screening.